GMH HP 150IU INJECTION

GMH HP 150IU Injection contains the active ingredient Menotrophin. This is an ovulation-stimulating agent which is part of the family of drugs known as gonadotropins. It is a pure mixture of follicle-stimulating hormone (FSH) and the luteinizing hormone (LH). These are hormones that males and females naturally produce. They help the reproductive organs work every day.
GMH HP 150IU Injection is used to treat infertility for women who have not been able to ovulate and have polycystic Ovarian Disease and who have not been able to respond to treatment with a different medication called clomiphene citrate. It can also assist multiple follicles and, thus, promote fertility for women who undergo IVF (in-vitro fertilization) or other forms of assisted conception. It can also be used for treating infertility in males due to a lower sperm count.
Don’t use GMH HP150IU injection if you are sensitive to menotrophin or any of the other components of this medication. Don’t take this medication if you are suffering from an abnormal pituitary gland (a gland at the brain’s base that produces hormones, which include growth hormones) or in the hypothalamus (a part of the brain’s thalamus called the thalamus that regulates the internal conditions of your body like blood pressure and temperature) as well as in the uterus and ovaries testicles, breasts or the prostate gland. Before starting treatment, you’ll be evaluated for thyroid problems, hormone levels, and tumors in the hypothalamus and pituitary glands.
Don’t take this medicine if you suffer from Ovarian cysts that aren’t caused by PCOD bleeding from the vagina or menopausal symptoms, issues with the reproductive organs if your womb was removed, or if you are breastfeeding or pregnant. Contact your doctor immediately if you experience any of these symptoms like abdominal pain, swelling and diarrhea, weight gain and breathing difficulties, and a decrease in urine output. Inform your doctor if you’ve been diagnosed with liver problems or had a history of blood-clotting disease before starting treatment.